257 related articles for article (PubMed ID: 5821999)
1. [The coronary dilatator effect of various reference drugs].
Duchene-Marullaz P; Cosnier D; Grimald J
Therapie; 1969; 24(4):617-20. PubMed ID: 5821999
[No Abstract] [Full Text] [Related]
2. The effectiveness of lidoflazine and other coronary vasodilators after oral administration in the trained non-anesthetized dog.
Jageneau A; Schaper W
Arzneimittelforschung; 1967 May; 17(5):582-7. PubMed ID: 4969448
[No Abstract] [Full Text] [Related]
3. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708
[No Abstract] [Full Text] [Related]
4. [Sympatholytic ("antisympathotonic") substances].
Kruger K
Minerva Med; 1968 Dec; 59(96):5227-30. PubMed ID: 5710726
[No Abstract] [Full Text] [Related]
5. [Efficiency of human cardiac action by coronary dilators].
Schirmer R; Hamacher J
Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):440. PubMed ID: 4253863
[No Abstract] [Full Text] [Related]
6. [Verapamil in the treatment of angina pectoris].
Sandler G
Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1323+. PubMed ID: 4991636
[No Abstract] [Full Text] [Related]
7. Effect of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates.
Winbury MM; Howe BB; Hefner MA
J Pharmacol Exp Ther; 1969 Jul; 168(1):70-95. PubMed ID: 4978326
[No Abstract] [Full Text] [Related]
8. [Pharmacologic bases of antiangina properties of amiodarone].
Charlier R
Brux Med; 1970 Sep; 50(9):651-6. PubMed ID: 5510367
[No Abstract] [Full Text] [Related]
9. Pharmacological aspects of the coronary circulation.
Parratt JR
Prog Med Chem; 1969; 6():11-66. PubMed ID: 4307053
[No Abstract] [Full Text] [Related]
10. [Drug therapy of angina pectoris. Evaluation of various drugs by means of work tests].
Kaltenbach M
Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1304+. PubMed ID: 4991635
[No Abstract] [Full Text] [Related]
11. [Screening of substances with coronary vasodilator action].
Lenke D
Arzneimittelforschung; 1970 May; 20(5):655-67. PubMed ID: 5468054
[No Abstract] [Full Text] [Related]
12. [Verapamil in the treatment of patients with coronary insufficiency].
Savenkov PM; Doscicin VL; Zarov EI; Arsakuni RO
Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1287+. PubMed ID: 4098328
[No Abstract] [Full Text] [Related]
13. [Comparison of therapeutic agents for angina pectoris from the standpoint of experimental cardiodynamics--method of evaluation of chronotropism and inotropism].
Ishiyama T; Morita Y; Tsukamoto N
Nihon Rinsho; 1971 Sep; 29(9):2159-66. PubMed ID: 4399196
[No Abstract] [Full Text] [Related]
14. [Old and new concepts of antistenocardiac drugs].
Sanna GP
Cardiol Prat; 1970 Dec; 21(6):367-82. PubMed ID: 4994206
[No Abstract] [Full Text] [Related]
15. [Dependence of pharmacodynamically produced changes of the arteriovenous oxygen difference of the heart on the extracellular pH].
Wolner E; Kraupp O
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966; 253(2):298-309. PubMed ID: 4222747
[No Abstract] [Full Text] [Related]
16. The effects of coronary vasodilators on coronary and systemic circulation. Experiments on the hearts of anesthetized dogs.
Seta K
Jpn Circ J; 1970 Jun; 34(6):499-511. PubMed ID: 5537669
[No Abstract] [Full Text] [Related]
17. [Separation of the divalent Ca++ antagonistic effect component from the beta-adrenolytic effects of cardio-depressive drugs on cultures of embryonic heart muscle cells].
Kaufmann R; Tritthart H; Rost B
Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):252-3. PubMed ID: 4242400
[No Abstract] [Full Text] [Related]
18. [The inherent contractility-reducing effect of various beta-adrenolytic agents on a heart-lung preparation in the dog].
Schmidt HD; Schmier J
Z Kreislaufforsch; 1967 Nov; 56(11):1137-50. PubMed ID: 5595876
[No Abstract] [Full Text] [Related]
19. [Selective inhibition of myocardial contractility by competitive divalent Ca++ antagonists (iproveratril, D 600, prenylamine)].
Fleckenstein A; Tritthart H; Fleckenstein B; Herbst A; Grün G
Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):227-8. PubMed ID: 4242380
[No Abstract] [Full Text] [Related]
20. [Metabolic effects of various palliative drugs for coronary insufficiency].
Deltour G
Therapie; 1970; 25(2):293-322. PubMed ID: 4404034
[No Abstract] [Full Text] [Related]
[Next] [New Search]
